Medicare Enrolled
Dr. Ayad Khourdaji, M.D.
Urology Physician · Lodi, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khourdaji from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khourdaji?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khourdaji
Dr. Ayad Khourdaji is an urology physician in Lodi, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. Khourdaji performed 12,389 Medicare services across 2,493 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khourdaji received a total of $6,654 from 40 pharmaceutical and/or device companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khourdaji is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 10% volume in CA
$6,654 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,389
Medicare services
Top 10% in CA for urology physician
2,493
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~953 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams. |
8,802 | $0 | $0 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
665 | $67 | $198 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
544 | $98 | $280 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
501 | $2 | $5 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 303 | $129 | $463 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
257 | $9 | $30 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
202 | $202 | $664 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
193 | $49 | $198 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
172 | $119 | $360 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $11 | $40 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $136 | $392 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
72 | $48 | $254 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
50 | $179 | $648 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
47 | $28 | $101 |
| New patient office visit, complex (60-74 min) | 47 | $158 | $476 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
44 | $64 | $147 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
43 | $36 | $3,451 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
43 | $101 | $278 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
35 | $271 | $868 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
31 | $317 | $1,061 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
25 | $20 | $64 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
20 | $569 | $1,861 |
| Prostate radiation therapy device placement A device is placed in the prostate to facilitate radiation therapy. This procedure involves positioning the device to aid in the delivery of radiation treatment. |
20 | $119 | $403 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
18 | $10 | $134 |
| Injection of biodegradable material next to prostate A procedure involving the injection of a biodegradable substance into the tissue surrounding the prostate gland. |
15 | $2,538 | $11,835 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $141 | $408 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
14 | $94 | $648 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
12 | $72 | $231 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
11 | $161 | $4,430 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
75.8% medium
23.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,654
Total received (2018-2024)
Avg $951/year across 7 years
Top 27% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
204
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,582 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$72 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,033
2023
$481
2022
$981
2021
$721
2020
$180
2019
$1,515
2018
$1,742
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$478
Antares Pharma, Inc.
$185
ABBVIE INC.
$164
Sumitomo Pharma America, Inc.
$66
Endo USA, Inc.
$40
ACCORD HEALTHCARE, INC.
$25
Boston Scientific Corporation
$24
ConvaTec Inc.
$22
KOELIS Inc.
$15
C. R. Bard, Inc. & Subsidiaries
$15
Top 3 companies account for 80.0% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$1,783
NeoTract Inc.
$893
Boston Scientific Corporation
$636
PROCEPT BioRobotics Corporation
$478
COLOPLAST CORP
$361
Astellas Pharma US Inc
$294
ABBVIE INC.
$269
Antares Pharma, Inc.
$223
Janssen Biotech, Inc.
$160
C. R. Bard, Inc. & Subsidiaries
$151
Teleflex LLC
$139
HealthTronics Mobile Solutions, LLC
$129
Sumitomo Pharma America, Inc.
$124
Augmenix, Inc.
$123
Allergan, Inc.
$109
TOLMAR Pharmaceuticals, Inc.
$95
AbbVie Inc.
$84
ACCORD HEALTHCARE, INC.
$59
Supernus Pharmaceuticals, Inc.
$51
IsoRay, Inc
$47
Endo USA, Inc.
$40
Myriad Genetic Laboratories, Inc.
$40
KOELIS Inc.
$30
BOSTON SCIENTIFIC CORPORATION
$29
UROGEN PHARMA, INC.
$26
Ferring Pharmaceuticals Inc.
$26
Allergan Inc.
$24
Retrophin, Inc.
$23
Ortho Dermatologics, a division of Bausch Health US, LLC
$22
ConvaTec Inc.
$22
PFIZER INC.
$21
Laborie Medical Technologies Corp.
$19
DENTSPLY IH AB
$18
Bard Access Systems, Inc.
$18
Sagent Pharmaceuticals, Inc.
$17
Olympus America Inc.
$16
Agiliti Surgical, Inc.
$16
Amniox Medical, Inc.
$15
RGH Enterprises, Inc.
$15
UroGen Pharma, Inc.
$13
Top 3 companies account for 49.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS Ambicor · AQUABEAM SYSTEM · BOTOX · BOTOX - UROLOGY · BRAC CDx · Bard Urinary Drainage Bag · Brachytherapy Source · CAMCEVI · ELIGARD · Erleada · FIRMAGON · GEMTESA · GENTLECATH · GREENLIGHT · Genesis · Glydo · JELMYTO · LITHOVUE · LUPRON DEPOT · LoFric · Mobile Cryoblation Services · Myrbetriq · NEOX · NOCDURNA · Prolaris · RETIN-A-MICRO · Rezum Generator · Solyx SIS System · SpaceOAR · SpeediCath · TITAN · Titan · Tremfya · Trinity · UROLIFT · UroLift · UroLift System · XIAFLEX · XTANDI · XYOSTED · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
21
Per 100K population
2.7
County median income
$88,531
Nearest hospital
ST JOSEPH'S MEDICAL CENTER OF STOCKTON
11.8 mi
11.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khourdaji is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khourdaji experienced with testosterone injection?
Based on Medicare claims data, Dr. Khourdaji performed 8,802 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khourdaji receive payments from pharmaceutical companies?
Yes. Dr. Khourdaji received a total of $6,654 from 40 companies across 204 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khourdaji's costs compare to other urology physicians in Lodi?
Dr. Khourdaji's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khourdaji) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Lodi
Browse urology physicians in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology